Metastatic Urothelial Carcinoma
Oncology·MeSH: Carcinoma, Transitional Cell
Prevalence
61.0 / 100K
Incidence
18.0 / 100K/yr
11 drugs in development·5 companies·17 clinical trials
Drug Pipeline by Phase
Phase 3(3)
Phase 2(6)
Compare drugs
Frequently asked questions
How many drugs are in development for Metastatic Urothelial Carcinoma?
BioSniper tracks 11 drugs in development for Metastatic Urothelial Carcinoma across 5 companies.
How many clinical trials target Metastatic Urothelial Carcinoma?
There are 17 clinical trials targeting Metastatic Urothelial Carcinoma tracked by BioSniper.
What is the prevalence of Metastatic Urothelial Carcinoma?
The estimated prevalence of Metastatic Urothelial Carcinoma is approximately 61.0 per 100,000 population.
Deep-dive into Metastatic Urothelial Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis